Introduction
An increasing number of patients are undergoing cardiac surgery [1] and in most cases a cardiopulmonary bypass (CPB) is required. This technique is aggressive and the patients are subjected to a high degree of surgical risk [2, 3] . In addition to the unphysiological hemodynamic conditions, one significant complication arising from CPB is the ischemia-reperfusion sequence syndrome, in which a large number of free radicals are generated, among other causes, because of the metabolism of xanthine oxidase, the activation of neutrophils, and the oxidation of catecholamines and prostaglandins [4] [5] [6] [7] [8] [9] . These radicals give rise to a considerable degree of cell injury, both structural and functional, involving among other effects, damage to membrane lipids [10, 11] . Several authors have shown a correlation between membrane rigidity and the degree of lipid peroxidation [11] [12] [13] . As intactness and structural integrity of biological membranes are prerequisites for the proper maintenance of cellular functions, changes in membrane fluidity contribute substantially to alterations in cellular functions [12] [13] [14] . Thus, in the case of cardiac surgery the increase in the generation of free radicals after starting CPB could alter the fluidity of cellular membrane and, thereby, increase the possibility of postoperative complications and mortality in these patients. It is therefore important to identify antioxidative molecules which are able to stabilize membranes and protect against lipid peroxidation.
In the last decade, melatonin has been shown to be a highly effective antioxidant and free radical scavenger [15] [16] [17] [18] . This molecule also has a regulatory effect on the activities of antioxidant enzymes [19, 20] , on enzymes involved in the generation of free radicals and on microsomal membrane fluidity in situations of elevated oxidative stress [21] [22] [23] [24] . These functions, in conjunction with its solubility in lipid and aqueous media, by which it is able to cross morphophysiological barriers and enter subcellular compartments [25] , permit melatonin to function as a highly effective inhibitor of oxidative damage.
The aim of this study was twofold. First, to determine whether there are changes in erythrocyte membrane fluidity during cardiac surgery involving CPB bypass and, secondly, to examine whether melatonin would suppress Abstract: The first aim of this study was to test whether there are changes in erythrocyte lipid peroxidation products and membrane fluidity during cardiac surgery involving cardiopulmonary bypass. Secondly, in vitro tests were performed to examine whether melatonin alters induced lipid peroxidation and reduced membrane fluidity in erythrocytes from these patients. Fifteen patients undergoing cardiac surgery involving cardiopulmonary bypass (CPB) were selected. Five blood samples were taken at different times during surgery for analysis of thiobarbituric acid reactive substances (TBARS) content and membrane fluidity of the erythrocytes. TBARS are an index of the level of lipid peroxidation. The results revealed an increase in TBARS levels and a parallel decrease in erythrocyte membrane fluidity (increased membrane rigidity) after the onset of CPB with respect to the reference sample. Likewise, in vitro induction of lipid peroxidation in the erythrocyte samples from CPB patients followed a similar pattern. The changes in TBARS levels and membrane fluidity were suppressed by preincubation of erythrocytes with melatonin prior to the induction (by 70 lm Fe 2+ + 250 lm ascorbate) of lipid peroxidation in a concentrationdependent manner. The results constitute a persuasive argument for the use of melatonin for preventive and therapeutic purposes during CPB.
changes in both membrane fluidity and generation of free radical reaction products in erythrocytes from these patients after the in vitro induction of lipid peroxidation.
Materials and methods

Patients
Fifteen patients undergoing cardiac surgery and considered to be at a high/severe level of surgical risk according to the Pettigrew scale [26] (which analyses several different indicators of the risk of surgery), were selected for inclusion in this study. The mean age was 58.0 ± 2.8 yr and duration of the surgery was 229 ± 11 min. The clinical characteristics of the patients are given in Table 1 . The following conditions were applied as general criteria for inclusion in the project: (a) 20 yr of age and over; (b) no hematological illness that might provoke a variation in erythrocyte levels; (c) not subjected to transfusion during the 3 months prior to surgery; (d) not subjected to prior surgery for valvuloplasty; (e) absence of endocrine illness and not receiving hormone treatment; (f) absence of severe or chronic anemia. All patients, in accordance with the Helsinki agreement, gave their informed consent to the study which was approved by the Ethics Committee of the Virgen de las Nieves Hospital, Granada, Spain.
Anesthetic and surgical procedures
The patients received scopolamine and midazolam before surgery. Non-invasive monitoring was established and, under local anesthesia, the arterial system was cannulated. This procedure enables the internal monitoring of arterial tension and the patient's metabolic and blood-gas status. It was also used to obtain the blood samples (total volume 20 mL) required for this study. Samples were obtained as follows. The reference sample (T0) was collected immediately after cannulation of the arterial system, before surgical intervention. We then administered hypnotics, opiates and muscle-relaxing agents (etomidate, fentanyl and pancuronium bromide, respectively), performed endotracheal intubation and established mechanical ventilation.
Anesthesia was maintained with reperfusions of fentanyl, atracurio and propofol. Following this, the central vein was cannulated and surgery began. The second blood sample (T1) was taken 10 min after beginning sternotomy. The third sample (T2) was taken after 15 min of CPB, and the fourth sample (T3) after 45 min. The final sample (T4) was obtained 20 min after the removal of the coronary bypass.
Analytical results
All the chemicals and solvents, of highest grade available, were acquired from Sigma (St Louis, MO, USA) and Merck (Darmstadt, Germany). A 1-(4-trimethylammoniumphenyl)-6-phenyl-1, 3, 5-hexa-triene-p-toluene-sulfonate (TMA-DPH) was obtained from Molecular Probe (Eugene, OR, USA). Melatonin was diluted in ethanol and water and TMA-DPH in tetrahydrofuran and water. Solutions were freshly prepared just prior to use. Blood was collected in heparined tubes and centrifuged at 1750 g for 10 min at 4°C in a Beckman GS-6R refrigerated centrifuge (Beckman, Fullerton, CA, USA) to obtain plasma. The isolation of erythrocyte membranes was carried out by hypotonic hemolysis according to the protocol of Hanahan and Ekholm [27] . The concentration of proteins in erythrocyte membranes was determined by the method of Lowry et al. [28] , using bovine serum albumin as standard. Erythrocytes (0.2 mg/ml) were suspended in Tris-HCl buffer (pH 7.4) and then incubated at 37°C for 30 min with melatonin (0.6 and 2 mm). Lipid peroxidation was induced in the samples by adding Fe 2+ -ascorbate (70 and 280 lm, respectively) [29] and the incubations were carried out at 37°C for 30 min with shaking. Thiobarbituric acid reactive substances (TBARS) were measured spectrophotometrically [30, 31] . Samples were mixed with TBA and acetic acid (pH 3.0) and heated at 90°C for 30 min. To lower the metalcatalyzed auto-oxidation of lipids, Butylated hydroxytoluene (BHT) (0.01%) was added to the TBA reagent. After cooling, the chromogen was extracted in n-butanol and the absorbance of the organic phase was determined at 535 nm.
Membrane fluidity was measured in triplicates by fluorescence spectroscopy following a technique previously described [24] . Erythrocyte membranes (0.2 mg/mL) were resupended in Tris-HCl buffer, vortexed for 1 min in the presence of TMA-DPH and then incubated with shaking at 37°C for 30 min to ensure the uniform incorporation of the probe into the membranes. Fluorescence polarization (P) measurements were performed using a Perkin Elmer LS 50 Luminescence Spectrometer (Perkin Elmer, Boston, MA, USA). Excitation and emission wavelengths were 365 and 430 nm, respectively. P was obtained from the fluorescence intensities parallel (I VV ) and perpendicular (I VH ) to the polarization direction of excitation light using the equation P ¼ (I VV ) GI VH ) ) (I VV + GI VH ), where G is an instrumental correction factor. Fluorescence values were also corrected for light scattering contributions by means of unlabeled membrane suspensions. Because an inverse relationship exists between membrane fluidity and polarization, membrane fluidity is expressed as the inverse of P (1/P).
For the in vitro study, both determinations, i.e. TBARS content and membrane fluidity, were performed on erythrocyte samples after incubation with 70 lm Fe 2+ plus 250 lm ascorbate only or in combination with either 0.6 or 2.0 mm melatonin.
Statistical analysis
Results are presented as mean ± S.E. One-way analysis of variance was used to test the time-dependent changes. Statistically significant differences (P < 0.05) were determined using a StudentÔs t-test and Bonferroni correction was used in case of multiple comparisons. Statistical processing was carried out using the SPSS package (SPSS for Windows, 9.0.1, 1999; SPSS Inc., Chicago, IL, USA).
Results
In vivo erythrocytes from patients undergoing cardiac surgery involving CPB showed a statistically significant increase in TBARS content (Table 2 ) at T2 (sample obtained 15 min after onset of surgery). At T3 (45 min after surgery onset) the TBARS content remained higher than the T0 values, but the difference was not statistically different relative to T0 valves. Membrane fluidity (Table 3) decreased (became more rigid) at T2 and T3 and were with statistically significant difference with respect to the reference level (T0). After the in vitro induction of lipid peroxidation in erythrocyte membranes by adding Fe 2+ -ascorbate, TBARS concentrations (Table 2) increased and membrane fluidity (Table 3) decreased with statistically significant differences with respect to the control group. The elevated values of TBARS were observed at T2 and T3, with statistically significant differences with respect to the reference level (T0). At T4, the TBARS levels remain elevated, but without statistically significant differences with respect to T0. Membrane fluidity followed an inverse pattern, with the lower values a T2 and T3. When erythrocytes from CPB patients were incubated with a combination of melatonin (either 0.6 or 2.0 mm) and Fe 2+ -ascorbate, the indole reduced the level of lipid peroxidation (Table 2 ) and the changes in membrane fluidity (Table 3) were caused by the free radical generating agents. For both endpoints, the 2.0 mm concentration of melatonin was more effective in reversing these changes than was the 0.6 mm concentration.
Discussion
Cardiac surgery normally involves CPB. This procedure induces free radical generation [5] [6] [7] [8] [9] , which results in damage to membrane lipids [10] and changes in the fluidity of cellular membranes [12, 13, 24, 31] . This is important because biological membranes function as a selective barrier which is essential for transport, enzyme activity, ion permeability, etc., and these functions require the Table 2 . Effect of incubation with melatonin prior to induction of lipid peroxidation (with Fe Values shown are mean ± S.E.M. *P < 0.05 compared with the reference sample (T0). **P < 0.05 versus control group. ***P < 0.05 versus ascorbate group. structural integrity and the maintenance of proper fluidity of the membrane [12] [13] [14] . Thus, it is important to determine whether there are changes in membrane fluidity as a result of CPB and to identify antioxidant molecules which are capable of stabilizing cellular membranes. One of these antioxidants is melatonin, which has been shown to be a highly effective antioxidant and free radical scavenger [11, 15, 17, 21, 32] and which has been found to maintain membrane fluidity of hepatic microsomal membranes of rats at the optimal level [24, 31] .
The aim of the current study was twofold. First, to test whether there are changes in erythrocyte lipid peroxidation and membrane fluidity during cardiac surgery involving CPB and, secondly, to examine whether melatonin would suppress changes in these parameters in erythrocytes from these patients after in vitro induction of lipid peroxidation. With respect to the first aim, the results indicate a sharp increase in erythrocyte TBARS content in response to CPB. Parallel to this increase in TBARS generation, there was a reduction in erythrocyte membrane fluidity, with the lowest value at T2 (15 min after the onset of CPB). These results support the hypothesis of increased oxidative stress in patients undergoing open-heart surgery including CPB [3, 5, 8] . Previous studies have examined lipid peroxidation products in the plasma but have not measured erythrocyte membrane fluidity.
The information regarding the reduction in erythrocyte membrane fluidity (increased membrane rigidity) during CPB surgery is important, because the membrane requires proper fluidity for optimal cell physiology. The reduction observed may well contribute to alterations in erythrocyte functions and therefore increase the possibility of postoperative complications and mortality in these patients.
After the induction of lipid peroxidation in erythrocytes from CPB patients by adding Fe 2+ -ascorbate, both TBARS and membrane fluidity were altered. The higher values for TBARS were found at T2 and T3. In parallel, the lower values for membrane fluidity were found at T2 and T3, reflecting membrane rigidity. However, when erythrocyte membranes treated with Fe 2+ -ascorbate were incubated with melatonin (0.6 and 2 mm) prior to the induction of lipid peroxidation, the changes in both TBARS levels and membrane rigidity decreased in a concentration-dependent manner. Thus, melatonin at 2 mm suppressed totally the change in membrane fluidity after induced lipid peroxidation. This was also the case with TBARS levels where a 2.0 mm concentration of melatonin lowered levels to those in CBP patients.
Indoles related to melatonin have a similar effect on TBARS and membrane fluidity [31, 33] . Melatonin's capacity to reduce membrane rigidity under conditions of high oxidative stress indicates that its mechanism of action relates to its antioxidant activity which in turn reduces lipid peroxidation [11, 15, 34] . If we consider that the induced lipid peroxidation in erythrocyte membranes from patients undergoing cardiac surgery are similar to the oxidative stress that occurs during cardiac surgery, then giving melatonin in advance at surgery may be useful in reducing the negative effects that occur during CPB surgery.
The results, together with the fact that melatonin exhibits reduced synthesis in patients with coronary artery disease [35] , constitute a persuasive argument for the use of melatonin for preventive and therapeutic purposes during CPB surgery. Given its potent antioxidant effects together with its capacity to cross morphophysiological barriers, its virtual absence of toxicity and ease of administration, melatonin may have utility in the therapeutic application against surgically induced oxidative stress. The results of this study also are consistent with other reports where melatonin was successfully used in humans to reduce oxidative stress [36] [37] [38] .
